Vycor Medical (VYCO) Change in Accured Expenses (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Change in Accured Expenses data on file, last reported at $11836.0 in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 138.01% year-over-year to $11836.0 in Q1 2026; TTM through Mar 2026 was $90974.0, a 144.04% increase from a year earlier, with the FY2025 full-year figure at $48000.0, changed 0.28% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $11836.0, down from $12099.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for VYCO reached as high as $104627.0 in Q3 2025 and fell as low as -$48693.0 in Q3 2022.
• Historically, Change in Accured Expenses has averaged $7080.1 across 5 years, with a median of $11836.0 in 2026.
• Across the five-year window, Change in Accured Expenses plunged 305.32% in 2024 and surged 764.83% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$6093.0 in 2022, then surged by 395.49% to $18004.0 in 2023, then tumbled by 32.8% to $12099.0 in 2024, then changed by 0.0% to $12099.0 in 2025, then decreased by 2.17% to $11836.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $11836.0 in Q1 2026, $12099.0 in Q4 2025, and $104627.0 in Q3 2025.